BLK and primary cutaneous T-cell non-Hodgkin lymphoma: Blk was only detected as the marker for the C5, and it was found tumour suppressive in chronic myeloid leukaemia stem cells (51) and oncogenic in cutaneous T-cell lymphoma (52).